Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Chinook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:05 pm Purchase |
2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Frazier Life Sciences Public Fund, L.P. | 4,052,510 6.300% |
1,282,484 (+46.30%) |
Filing |
| 2022-04-29 12:19 pm Purchase |
2022-04-21 | 13G | Chinook Therapeutics, Inc. KDNY |
Frazier Life Sciences Public Fund, L.P. | 2,770,026 5.000% |
2,770,026 (New Position) |
Filing |